Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Diabetes

  Free Subscription


Articles published in BMJ

Retrieve available abstracts of 125 articles:
HTML format



Single Articles


    July 2020
  1. CAI X, Zhang Y, Li M, Wu JH, et al
    Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis.
    BMJ. 2020;370:m2297.
    PubMed     Abstract available


  2. HU Y, Ding M, Sampson L, Willett WC, et al
    Intake of whole grain foods and risk of type 2 diabetes: results from three prospective cohort studies.
    BMJ. 2020;370:m2206.
    PubMed     Abstract available


  3. ZHENG JS, Sharp SJ, Imamura F, Chowdhury R, et al
    Association of plasma biomarkers of fruit and vegetable intake with incident type 2 diabetes: EPIC-InterAct case-cohort study in eight European countries.
    BMJ. 2020;370:m2194.
    PubMed     Abstract available


  4. BURNS VF
    I live with "the world's most dangerous" eating disorder.
    BMJ. 2020;370:m1886.
    PubMed    


    June 2020
  5. MCMILLAN B, Boyd J, Mitchell C
    Enhancing postnatal care of women with gestational diabetes.
    BMJ. 2020;369:m2414.
    PubMed    


  6. KAR P
    Partha Kar: Covid-19-time for parity in commissioning diabetes services.
    BMJ. 2020;369:m2154.
    PubMed    


    May 2020
  7. VOUNZOULAKI E, Khunti K, Abner SC, Tan BK, et al
    Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis.
    BMJ. 2020;369:m1361.
    PubMed     Abstract available


  8. RICHARDSON TG, Sanderson E, Elsworth B, Tilling K, et al
    Use of genetic variation to separate the effects of early and later life adiposity on disease risk: mendelian randomisation study.
    BMJ. 2020;369:m1203.
    PubMed     Abstract available


    April 2020
  9. BHASALE A, Mintzes B, Sarpatwari A
    Communicating emerging risks of SGLT2 inhibitors-timeliness and transparency of medicine regulators.
    BMJ. 2020;369:m1107.
    PubMed    


  10. PASTERNAK B, Wintzell V, Melbye M, Eliasson B, et al
    Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study.
    BMJ. 2020;369:m1186.
    PubMed     Abstract available


  11. LI Y, Teng D, Shi X, Qin G, et al
    Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study.
    BMJ. 2020;369:m997.
    PubMed     Abstract available


  12. MATHIESON S, Lin CC, Underwood M, Eldabe S, et al
    Pregabalin and gabapentin for pain.
    BMJ. 2020;369:m1315.
    PubMed    


  13. DIAB J, Bannan A, Pollitt T
    Necrotising fasciitis.
    BMJ. 2020;369:m1428.
    PubMed    


    March 2020

  14. Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease?
    BMJ. 2020;368:m1270.
    PubMed    


  15. IACOBUCCI G
    Covid-19: diabetes clinicians set up social media account to help alleviate patients' fears.
    BMJ. 2020;368:m1262.
    PubMed    


  16. EXTANCE A
    Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease?
    BMJ. 2020;368:m1174.
    PubMed    


  17. VALABHJI J
    Rapid access to multidisciplinary diabetes foot care teams.
    BMJ. 2020;368:m773.
    PubMed    


    February 2020
  18. MCCORMACK JP, Holmes DT
    Your results may vary: the imprecision of medical measurements.
    BMJ. 2020;368:m149.
    PubMed    


  19. ROY MP
    Improving nutrition in India: encouraging informed food choices.
    BMJ. 2020;368:m367.
    PubMed    


  20. VAN DUINEN GL
    Healthy lifestyle and life expectancy: fund prevention programmes to end the cycle of preventable morbidity.
    BMJ. 2020;368:m427.
    PubMed    


  21. CRAIG MF
    We shouldn't recommend harmful foods "in moderation".
    BMJ. 2020;368:m365.
    PubMed    


    January 2020
  22. FEINMANN J
    Hope for diabetes: five minutes with David Unwin.
    BMJ. 2020;368:m404.
    PubMed    


  23. COOK R, Davidson P, Martin R
    Losing weight following diagnosis of type 2 diabetes boosts chance of remission.
    BMJ. 2020;368:l6775.
    PubMed     Abstract available


  24. KAR P
    Partha Kar: What will the 2020s hold for diabetes care?
    BMJ. 2020;368:m202.
    PubMed    


  25. LI Y, Schoufour J, Wang DD, Dhana K, et al
    Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: prospective cohort study.
    BMJ. 2020;368:l6669.
    PubMed     Abstract available


    December 2019
  26. YU Y, Arah OA, Liew Z, Cnattingius S, et al
    Maternal diabetes during pregnancy and early onset of cardiovascular disease in offspring: population based cohort study with 40 years of follow-up.
    BMJ. 2019;367:l6398.
    PubMed     Abstract available


    November 2019
  27. RODRIGUEZ-GUTIERREZ R, Gonzalez-Gonzalez JG, Zuniga-Hernandez JA, McCoy RG, et al
    Benefits and harms of intensive glycemic control in patients with type 2 diabetes.
    BMJ. 2019;367:l5887.
    PubMed     Abstract available


    October 2019
  28. MIRZAZADEH M, Alijani E, Fani M, Jamili S, et al
    A 44 year old woman with episodic sweating and hypertension.
    BMJ. 2019;367:l5879.
    PubMed    


  29. SPILSBURY C, Panahi M, Bowsher G, Sadighi A, et al
    A young woman with dyspnoea and oedema.
    BMJ. 2019;367:l5763.
    PubMed    


  30. IACOBUCCI G
    Diabetes technology: specialists are blocking access for some patients, say experts.
    BMJ. 2019;367:l6085.
    PubMed    



  31. Quality of dietary fat and genetic risk of type 2 diabetes: individual participant data meta-analysis.
    BMJ. 2019;367:l5612.
    PubMed    


  32. IACOBUCCI G
    Thousands more patients with type 1 diabetes are getting flash glucose devices, data show.
    BMJ. 2019;367:l5895.
    PubMed    


    September 2019
  33. HENDERSON G
    Whether one burns fat, and not the type of fat one eats, is the important thing in type 2 diabetes.
    BMJ. 2019;366:l5700.
    PubMed    


  34. HOOPER L, Brown T, Brainard J, Abdelhamid A, et al
    Authors' reply to Henderson.
    BMJ. 2019;366:l5703.
    PubMed    


  35. LEAN M, McCombie L, McSorely J
    Trends in type 2 diabetes.
    BMJ. 2019;366:l5407.
    PubMed    


  36. MAGLIANO DJ, Islam RM, Barr ELM, Gregg EW, et al
    Trends in incidence of total or type 2 diabetes: systematic review.
    BMJ. 2019;366:l5003.
    PubMed     Abstract available


    August 2019
  37. PASTERNAK B, Ueda P, Eliasson B, Svensson AM, et al
    Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study.
    BMJ. 2019;366:l4772.
    PubMed     Abstract available


  38. LIND M, Pivodic A, Svensson AM, Olafsdottir AF, et al
    HbA1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study.
    BMJ. 2019;366:l4894.
    PubMed     Abstract available


  39. BROWN TJ, Brainard J, Song F, Wang X, et al
    Omega-3, omega-6, and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled trials.
    BMJ. 2019;366:l4697.
    PubMed     Abstract available


  40. MAHASE E
    Progress in diabetes care has not improved outcomes in US, study finds.
    BMJ. 2019;366:l5166.
    PubMed    


    July 2019
  41. MERINO J
    Quality of dietary fat and genetic risk of type 2 diabetes: individual participant data meta-analysis.
    BMJ. 2019;366:l4292.
    PubMed     Abstract available


  42. NEUENSCHWANDER M, Ballon A, Weber KS, Norat T, et al
    Role of diet in type 2 diabetes incidence: umbrella review of meta-analyses of prospective observational studies.
    BMJ. 2019;366:l2368.
    PubMed     Abstract available


  43. JIAO J, Liu G, Shin HJ, Hu FB, et al
    Dietary fats and mortality among patients with type 2 diabetes: analysis in two population based cohort studies.
    BMJ. 2019;366:l4009.
    PubMed     Abstract available


    June 2019
  44. WISE J
    The wrong diabetes: how C peptide testing might help.
    BMJ. 2019;365:l4352.
    PubMed    


  45. SHEIKH Z, Akali A
    An unstable lump in the groin.
    BMJ. 2019;365:l2214.
    PubMed    


    May 2019
  46. KARSLIOGLU FRENCH E, Donihi AC, Korytkowski MT
    Diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome: review of acute decompensated diabetes in adult patients.
    BMJ. 2019;365:l1114.
    PubMed     Abstract available


    April 2019
  47. MAHASE E
    Dentists could help detect diabetes and cardiovascular disease during oral health checks.
    BMJ. 2019;365:l1870.
    PubMed    


  48. BARRY E, Finnikin S
    A borderline HBA1c result.
    BMJ. 2019;365:l1361.
    PubMed    


  49. WEI L, Lai EC, Kao-Yang YH, Walker BR, et al
    Incidence of type 2 diabetes mellitus in men receiving steroid 5alpha-reductase inhibitors: population based cohort study.
    BMJ. 2019;365:l1204.
    PubMed     Abstract available


  50. MUSSO G, Gambino R, Cassader M, Paschetta E, et al
    Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials.
    BMJ. 2019;365:l1328.
    PubMed     Abstract available


  51. BLAIR JC, McKay A, Ridyard C, Thornborough K, et al
    Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
    BMJ. 2019;365:l1226.
    PubMed     Abstract available


    March 2019
  52. WISE J
    The BMJ Awards 2019: Diabetes Team of the Year.
    BMJ. 2019;364:l1232.
    PubMed    


  53. IACOBUCCI G
    Sixty seconds on . . . reversing type 2 diabetes.
    BMJ. 2019;364:l1128.
    PubMed    


  54. NEWMAN M
    Questions over future of global diabetes group as founding members resign.
    BMJ. 2019;364:l995.
    PubMed    


    February 2019
  55. LEVY M, Prentice M, Wass J
    Diabetes insipidus.
    BMJ. 2019;364:l321.
    PubMed    


  56. FEINMANN J
    Australian MPs visit Southport GP to learn about low carb diet for type 2 diabetes.
    BMJ. 2019;364:l659.
    PubMed    


  57. SCIBILIA R, Aldred C
    #TalkAboutComplications.
    BMJ. 2019;364:k5258.
    PubMed    


    January 2019
  58. KMIETOWICZ Z
    Fried food linked to increased risk of death among older US women.
    BMJ. 2019;364:l362.
    PubMed    


  59. IACOBUCCI G
    Sixty seconds on . . . medical detection dogs.
    BMJ. 2019;364:l302.
    PubMed    


  60. MAYOR S
    Delivering diabetes targets: five minutes with . . . Sam Everington.
    BMJ. 2019;364:l229.
    PubMed    


  61. MANFREDINI R, Cappadona R, Fabbian F
    Nurses, shift work, and diabetes: should late chronotype be considered as a risk factor?
    BMJ. 2019;364:l178.
    PubMed    


  62. SKOVENBORG E
    Shift work and diabetes: alcohol consumption as a risk factor.
    BMJ. 2019;364:l177.
    PubMed    


  63. SHAN Z, Bhupathiraju SN
    Authors' reply to Skovenborg and Manfredini and colleagues.
    BMJ. 2019;364:l179.
    PubMed    


  64. PILLING LC, Tamosauskaite J, Jones G, Wood AR, et al
    Common conditions associated with hereditary haemochromatosis genetic variants: cohort study in UK Biobank.
    BMJ. 2019;364:k5222.
    PubMed     Abstract available


  65. MAYOR S
    Diabetes: precision approach will improve outcomes, says research director.
    BMJ. 2019;364:l186.
    PubMed    


  66. SALISBURY H
    Helen Salisbury: When policy doesn't match evidence.
    BMJ. 2019;364:l54.
    PubMed    


    December 2018
  67. CHARLTON M
    Everyone with type 1 diabetes should have access to a flash glucose device.
    BMJ. 2018;363:k5204.
    PubMed    


  68. BLACK S
    Flash glucose monitoring devices: CCG criteria are incoherent.
    BMJ. 2018;363:k5203.
    PubMed    


  69. ADLER AI
    Incretins and cancer of the bile duct in type 2 diabetes.
    BMJ. 2018;363:k5155.
    PubMed    


  70. ABRAHAMI D, Douros A, Yin H, Yu OH, et al
    Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study.
    BMJ. 2018;363:k4880.
    PubMed     Abstract available


    November 2018
  71. FEINMANN J
    Type 2 diabetes: 5000 patients to test feasibility of "remission service".
    BMJ. 2018;363:k5114.
    PubMed    


  72. HENDLEY J
    Are you well controlled?
    BMJ. 2018;363:k3119.
    PubMed    


  73. SHAN Z, Li Y, Zong G, Guo Y, et al
    Rotating night shift work and adherence to unhealthy lifestyle in predicting risk of type 2 diabetes: results from two large US cohorts of female nurses.
    BMJ. 2018;363:k4641.
    PubMed     Abstract available


  74. IACOBUCCI G
    Type 2 diabetes affects 7000 young people in England and Wales, analysis shows.
    BMJ. 2018;363:k4929.
    PubMed    


  75. KMIETOWICZ Z
    Type 2 diabetes: sweetened drinks pose greater risk than other sugary foods.
    BMJ. 2018;363:k4943.
    PubMed    


  76. CHOO VL, Viguiliouk E, Blanco Mejia S, Cozma AI, et al
    Food sources of fructose-containing sugars and glycaemic control: systematic review and meta-analysis of controlled intervention studies.
    BMJ. 2018;363:k4644.
    PubMed     Abstract available


  77. SODI R, McKay K, Dampetla S, Pappachan JM, et al
    Monitoring glycaemic control in patients with diabetes mellitus.
    BMJ. 2018;363:k4723.
    PubMed    


  78. KMIETOWICZ Z
    SGLT2 inhibitors for diabetes are linked to increased risk of lower limb amputation.
    BMJ. 2018;363:k4828.
    PubMed    


  79. UEDA P, Svanstrom H, Melbye M, Eliasson B, et al
    Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study.
    BMJ. 2018;363:k4365.
    PubMed     Abstract available


  80. IACOBUCCI G
    NHS England tells CCGs to end postcode lottery over diabetes glucose devices.
    BMJ. 2018;363:k4812.
    PubMed    


  81. OWEN J
    Audit paints "bleak picture" of diabetes care in England and Wales.
    BMJ. 2018;363:k4780.
    PubMed    


  82. IACOBUCCI G
    Patients with type 1 diabetes are missing out on flash glucose devices, finds BMJ investigation.
    BMJ. 2018;363:k4675.
    PubMed    


  83. MILLETT ERC, Peters SAE, Woodward M
    Sex differences in risk factors for myocardial infarction: cohort study of UK Biobank participants.
    BMJ. 2018;363:k4247.
    PubMed     Abstract available


    October 2018
  84. KHANDWALA YS, Baker VL, Shaw GM, Stevenson DK, et al
    Association of paternal age with perinatal outcomes between 2007 and 2016 in the United States: population based cohort study.
    BMJ. 2018;363:k4372.
    PubMed     Abstract available


    September 2018
  85. MIETTINEN ME, Virtanen SM
    Dietary gluten and type 1 diabetes.
    BMJ. 2018;362:k3867.
    PubMed    


  86. ANTVORSKOV JC, Halldorsson TI, Josefsen K, Svensson J, et al
    Association between maternal gluten intake and type 1 diabetes in offspring: national prospective cohort study in Denmark.
    BMJ. 2018;362:k3547.
    PubMed     Abstract available


  87. RAMOS R, Comas-Cufi M, Marti-Lluch R, Ballo E, et al
    Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study.
    BMJ. 2018;362:k3359.
    PubMed     Abstract available


  88. XU G, Liu B, Sun Y, Du Y, et al
    Prevalence of diagnosed type 1 and type 2 diabetes among US adults in 2016 and 2017: population based study.
    BMJ. 2018;362:k1497.
    PubMed     Abstract available


    August 2018
  89. MAYOR S
    Type 1 diabetes: earlier onset is linked to cardiovascular complications and reduced lifespan.
    BMJ. 2018;362:k3487.
    PubMed    


  90. WISE J
    Diabetes: simple patient characteristics should help inform choice of second line drug, study finds.
    BMJ. 2018;362:k3368.
    PubMed    


    July 2018
  91. MCGOWAN LD, Roumie CL
    Sulfonylureas as second line treatment for type 2 diabetes.
    BMJ. 2018;362:k3041.
    PubMed    


  92. DOUROS A, Dell'Aniello S, Yu OHY, Filion KB, et al
    Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study.
    BMJ. 2018;362:k2693.
    PubMed     Abstract available


  93. FEGHALI MN, Scifres CM
    Novel therapies for diabetes mellitus in pregnancy.
    BMJ. 2018;362:k2034.
    PubMed     Abstract available


  94. LUDVIGSSON JF, Neovius M, Soderling J, Gudbjornsdottir S, et al
    Periconception glycaemic control in women with type 1 diabetes and risk of major birth defects: population based cohort study in Sweden.
    BMJ. 2018;362:k2638.
    PubMed     Abstract available


    June 2018
  95. ABALEM MF, Eagle KA, Rao RC
    Unilateral retinopathy in a patient with diabetes and coronary heart disease.
    BMJ. 2018;361:k1703.
    PubMed    


  96. FOROUHI NG, Misra A, Mohan V, Taylor R, et al
    Dietary and nutritional approaches for prevention and management of type 2 diabetes.
    BMJ. 2018;361:k2234.
    PubMed    


    May 2018
  97. DOBSON R, Whittaker R, Jiang Y, Maddison R, et al
    Effectiveness of text message based, diabetes self management support programme (SMS4BG): two arm, parallel randomised controlled trial.
    BMJ. 2018;361:k1959.
    PubMed     Abstract available


    April 2018
  98. CARRUTH L, Mendenhall E
    Social aetiologies of type 2 diabetes.
    BMJ. 2018;361:k1795.
    PubMed    


  99. STAERK L, Wang B, Preis SR, Larson MG, et al
    Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study.
    BMJ. 2018;361:k1453.
    PubMed     Abstract available


  100. WAUGH N, Adler A, Craigie I, Omer T, et al
    Closed loop systems in type 1 diabetes.
    BMJ. 2018;361:k1613.
    PubMed    


  101. BEKIARI E, Kitsios K, Thabit H, Tauschmann M, et al
    Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis.
    BMJ. 2018;361:k1310.
    PubMed     Abstract available


    March 2018
  102. STRINGHINI S, Carmeli C, Jokela M, Avendano M, et al
    Socioeconomic status, non-communicable disease risk factors, and walking speed in older adults: multi-cohort population based study.
    BMJ. 2018;360:k1046.
    PubMed     Abstract available


  103. HAWKES N
    Sixty seconds on . . . diabetes.
    BMJ. 2018;360:k1264.
    PubMed    


  104. ABRAHAMI D, Douros A, Yin H, Yu OHY, et al
    Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study.
    BMJ. 2018;360:k872.
    PubMed     Abstract available


  105. WISE J
    NHS diabetes prevention programme helps weight loss, analysis shows.
    BMJ. 2018;360:k1196.
    PubMed    


    February 2018
  106. PATORNO E, Goldfine AB, Schneeweiss S, Everett BM, et al
    Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study.
    BMJ. 2018;360:k119.
    PubMed     Abstract available


  107. MORLEY RL, Sharma A, Horsch AD, Hinchliffe RJ, et al
    Peripheral artery disease.
    BMJ. 2018;360:j5842.
    PubMed    


    January 2018
  108. TU H, Wen CP, Tsai SP, Chow WH, et al
    Cancer risk associated with chronic diseases and disease markers: prospective cohort study.
    BMJ. 2018;360:k134.
    PubMed     Abstract available


  109. WISE J
    NHS weight management programme makes clinical difference in patients with type 2 diabetes.
    BMJ. 2018;360:k177.
    PubMed    


  110. WENG J, Zhou Z, Guo L, Zhu D, et al
    Incidence of type 1 diabetes in China, 2010-13: population based study.
    BMJ. 2018;360:j5295.
    PubMed     Abstract available


    December 2017
  111. KMIETOWICZ Z
    GP based weight loss programme can reverse type 2 diabetes.
    BMJ. 2017;359:j5641.
    PubMed    


  112. WISE J
    Study links varicoceles to heart disease and diabetes.
    BMJ. 2017;359:j5569.
    PubMed    


    November 2017
  113. HIPPISLEY-COX J, Coupland C
    Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study.
    BMJ. 2017;359:j5019.
    PubMed     Abstract available


  114. MISHRA SC, Chhatbar KC, Kashikar A, Mehndiratta A, et al
    Diabetic foot.
    BMJ. 2017;359:j5064.
    PubMed    


  115. HAWKES N
    Sixty seconds on . . . semaglutide.
    BMJ. 2017;359:j5010.
    PubMed    


    October 2017
  116. KALLIALA I, Markozannes G, Gunter MJ, Paraskevaidis E, et al
    Obesity and gynaecological and obstetric conditions: umbrella review of the literature.
    BMJ. 2017;359:j4511.
    PubMed     Abstract available


  117. MAYOR S
    Type 3c diabetes associated with pancreatic disease is often misdiagnosed, finds study.
    BMJ. 2017;359:j4923.
    PubMed    


  118. MAYOR S
    GP referral to prevention programme helps prevent type 2 diabetes, study finds.
    BMJ. 2017;359:j4770.
    PubMed    


  119. MARJOT D
    Hunger can be the driving force behind "relapse" of type 2 diabetes.
    BMJ. 2017;359:j4728.
    PubMed    


  120. COUSINS S
    Diabetic patients with poor glycaemic control have higher risk of latent TB, study shows.
    BMJ. 2017;359:j4767.
    PubMed    


    September 2017
  121. MAYOR S
    Obesity surgery achieves long term weight loss and prevents type 2 diabetes, study finds.
    BMJ. 2017;358:j4376.
    PubMed    


  122. GULLAND A
    People at high risk of diabetes should undergo intensive lifestyle change, says NICE.
    BMJ. 2017;358:j4301.
    PubMed    


  123. MAYOR S
    Twenty four hour glucose monitoring halves adverse birth outcomes in pregnant women with type 1 diabetes, study finds.
    BMJ. 2017;358:j4294.
    PubMed    


  124. MCCOMBIE L, Leslie W, Taylor R, Kennon B, et al
    Beating type 2 diabetes into remission.
    BMJ. 2017;358:j4030.
    PubMed    


  125. DYER O
    France to prosecute its drug regulator and Servier in scandal over diabetes drug.
    BMJ. 2017;358:j4231.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: